|
市場調査レポート
商品コード
1384652
気管支鏡の世界市場規模、シェア、産業動向分析レポート:タイプ別、用途別、最終用途別、地域別展望と予測、2023年~2030年Global Bronchoscopes Market Size, Share & Industry Trends Analysis Report By Type (Flexible (Video, Fiberoptic, Hybrid), and Rigid), By Usage, By End Use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
気管支鏡の世界市場規模、シェア、産業動向分析レポート:タイプ別、用途別、最終用途別、地域別展望と予測、2023年~2030年 |
出版日: 2023年10月31日
発行: KBV Research
ページ情報: 英文 346 Pages
納期: 即納可能
![]() |
気管支鏡市場規模は、予測期間中にCAGR 6.9%で成長し、2030年には44億米ドルに達すると予測されます。2022年の市場規模は130万8,100台、成長率は9.6%です(2019-2022年)。
KBVカーディナルマトリックスに示された分析によると、ジョンソン・エンド・ジョンソンが同市場におけるトップランナーです。Medtronic PLC、Fujifilm Holdings Corporation、Olympus Corporationなどの企業は、市場における主要なイノベーターです。2022年7月、Medtronic PLCは気管支鏡手術に使用されるシステム、イルミシテの発売を発表しました。このシステムは、低侵襲設備、組織の異常に対するより良い可視性、病変に対するアクセスの拡大など、いくつかの利点を提供します。
COVID-19影響分析
COVID-19が最も影響を受けたシステムは呼吸器系であり、気管支鏡やその他の呼吸器系診断ツールの需要が急増しました。病院やヘルスケア施設はCOVID-19患者、特に重度の呼吸器症状を持つ患者の診断と治療のために気管支鏡を必要としました。多くのヘルスケア施設はリソースを再配分し、COVID-19関連のケアや機器を優先しなければならなかっています。パンデミックは、新しい医療機器や技術の開発など、ヘルスケア分野における研究開発を加速させました。その結果、気管支鏡のデザインや機能が革新されました。感染対策は、ヘルスケア現場における最優先事項となっています。メーカーやヘルスケアプロバイダーは、交差汚染のリスクを低減するため、気管支鏡の滅菌・洗浄プロトコルを強化しました。そのため、COVID-19の流行は市場に中程度の影響を与えました。
市場成長要因
呼吸器疾患の増加
肺がん、慢性閉塞性肺疾患(COPD)、喘息、肺炎などの呼吸器疾患の罹患率の増加が、診断と治療のための気管支鏡検査の需要を押し上げています。肺がんは、世界的にがん関連死亡の主要原因の一つです。診断、病期分類、治療計画のために気管支鏡下手術が必要とされることが多いです。気管支鏡検査による早期発見と正確な診断は、生存率を向上させるために非常に重要です。COPDは慢性気管支炎や肺気腫を含む疾患です。気管支鏡検査は、気道の炎症を評価し、診断のための組織サンプルを採取し、症状を管理し肺機能を改善するための治療的介入を行う。呼吸器疾患の有病率の上昇は市場成長の重要な促進要因です。
遠隔医療と遠隔診察の採用拡大
遠隔医療や遠隔ヘルスケアサービスの成長により、気管支鏡治療の範囲が拡大しています。ビデオ気管支鏡により、ヘルスケア専門家は遠隔診察や専門医との共同作業を行うことができます。遠隔医療は、遠隔地や十分なサービスを受けていない地域の患者が、気管支鏡検査やフォローアップ・ケアを含むヘルスケア・サービスを、医療施設まで長距離を移動することなく利用することを可能にします。遠隔医療は、ヘルスケアプロバイダーが患者と遠隔で診察を行うことを可能にします。気管支鏡の所見、画像、ビデオを専門家と共有し、評価や勧告を受けることができるため、地理的な場所に関係なく専門家の意見を聞くことができます。遠隔医療と遠隔ヘルスケアサービスの成長は、市場に大きな影響を与えています。
市場抑制要因
高い感染リスク
気管支鏡下手術には感染症のリスクが伴う。気管支鏡の適切な洗浄、消毒、滅菌を確実に行うことは、医療関連感染を防ぐために極めて重要です。気管支鏡は、複数のチャンネルとコンポーネントを持つ複雑な医療機器であるため、完全な洗浄が困難です。微生物のバイオフィルムを含む汚染物質は、隙間や流路に潜む可能性があり、感染伝播のリスクを高めます。気管支鏡の洗浄や再処理における人為的ミスは重大な懸念事項です。手作業による洗浄、消毒、滅菌のミスは、感染因子を保有する汚染物質を残す可能性があります。その結果、感染クラスターやアウトブレイクの発見が遅れる可能性があります。気管支鏡に関連する感染伝播のリスクは、ヘルスケア産業および市場において重要な課題となっています。
タイプ別展望
気管支内視鏡市場は、タイプ別に硬性タイプと軟性タイプに分類されます。光ファイバーセグメントは2022年の市場で大きな収益シェアを獲得しました。軟性気管支鏡は直径が小さく、侵襲性が低いため、処置中の患者の不快感や不安を軽減することができます。軟性気管支鏡は汎用性が高く、様々な診断・治療処置に使用できます。気管支や末梢気道を含む気道全体の観察に適しています。軟性気管支内視鏡は、その柔軟性により、気道内での操作やナビゲーションが容易です。軟性気管支鏡の利点は、患者に優しいデザイン、多用途性、高度な画像処理能力、様々な診断・治療用途への適合性などです。気管支鏡は呼吸器医療における標準的なツールとなり、肺や気道の障害の診断や治療に重要な役割を果たしています。
フレキシブル型の展望
フレキシブルタイプでは、市場はビデオ、光ファイバー、ハイブリッドに分けられます。2022年の市場では、光ファイバーセグメントが大きな収益シェアを獲得しました。光ファイバー気管支鏡は一般的に診断目的に使用されます。ヘルスケアプロバイダーが気管支樹を検査し、腫瘍、感染、異物、炎症などの異常を検出することができます。光ファイバー束が提供する光学的明瞭性により、正確な視覚化が可能です。光ファイバー気管支鏡は、気道の検査、気道開存性の評価、閉塞や病変の特定に使用されます。咳、喀血、喘鳴などの呼吸器症状を有する患者を評価するための貴重なツールです。光ファイバー気管支鏡は、食べかすや吸入物などの異物を見つけ、気道から除去するために使用されます。気管支鏡の柔軟性と操作性は、これらの処置の正確さを助けます。
用途別展望
用途別では、市場は再使用型と使い捨て型に分類されます。2022年の市場では、ディスポーザブルセグメントがかなりの収益シェアを占めています。使い捨て気管支鏡は、管理された条件下で製造されるため、各スコープが最適であることを保証します。この一貫性は、画質と機能性が不可欠な重要な処置において特に重要です。使い捨て気管支鏡は、セットアップ、キャリブレーション、滅菌の必要がなく、すぐに使用できるため、ヘルスケアプロバイダーは便利だと感じています。これは特に緊急時に有利です。ディスポーザブル気管支鏡は、再処理施設へのアクセスが制限されていたり、現実的でない遠隔地や現場での使用に適しています。
最終用途の展望
最終用途別では、市場は病院と外来施設に区分されます。2022年には、病院セグメントが市場で最大の収益シェアを記録しました。病院は診断目的で気管支鏡を使用します。気管支鏡を患者の気道に挿入し、気管、気管支、気管支を可視化します。これにより、腫瘍、感染、炎症、出血などの異常を特定することができます。気管支鏡によって気道から組織サンプルを採取し、病理部門に送って分析することもできます。病院では気管支鏡を治療目的に利用しています。薬剤の投与、喘息管理のための気管支サーモプラスティの実施、喀血(血を吐く)や狭窄(気道が狭くなる)などの疾患の治療に使用されます。
地域別展望
地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が最も高い収益シェアを獲得して市場をリードしました。この地域の高度なヘルスケアインフラは、気管支鏡を含む最新の医療技術や医療機器の導入を可能にしています。質の高いヘルスケア施設と熟練した労働力が市場の成長に貢献しています。北米は医療技術革新の中心地です。この地域のメーカーは、高精細画像、操作性の向上、デジタルシステムとの統合を実現したデジタルビデオ気管支鏡など、先進的な気管支鏡技術を継続的に開発・導入しています。
The Global Bronchoscopes Market size is expected to reach $4.4 billion by 2030, rising at a market growth of 6.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,308.1 thousand units, experiencing a growth of 9.6% (2019-2022).
Video bronchoscopes have high-resolution cameras and advanced imaging technologies, such as high-definition (HD) and 4K video capabilities. Hence, video segment would acquire approximately 1/2th share in the Flexible segment of the market by 2030. These technologies provide clear and detailed images of the respiratory tract, allowing healthcare professionals to visualize and assess the airway more effectively. Video bronchoscopes offer real-time visualization of the airway during procedures. This real-time feedback is crucial for diagnosing conditions, guiding interventions, and ensuring patient safety. Video bronchoscopes allow healthcare providers to document procedures by recording video and capturing images. This documentation can be used for patient records, education, and consultation with colleagues, contributing to improved patient care.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope. In November, 2022, Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter.
Based on the Analysis presented in the KBV Cardinal matrix; Johnson & Johnson is the forerunner in the Market. Companies such as Medtronic PLC, Fujifilm Holdings Corporation, Olympus Corporation are some of the key innovators in the Market. In July, 2022, Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.
COVID-19 Impact Analysis
The respiratory system was the system that COVID-19 most affected, which caused a spike in demand for bronchoscopes and other diagnostic tools for the respiratory system. Hospitals and healthcare facilities needed bronchoscopes to diagnose and treat COVID-19 patients, especially those with severe respiratory symptoms. Many healthcare facilities had to reallocate resources and prioritize COVID-19-related care and equipment. The pandemic accelerated research and development efforts in the healthcare sector, including developing new medical devices and technologies. This led to innovations in bronchoscope design and functionality. Infection control measures became a top priority in healthcare settings. Manufacturers and healthcare providers implemented enhanced sterilization and cleaning protocols for bronchoscopes to reduce the risk of cross-contamination. Therefore, COVID-19 pandemic had a moderate effect on the market.
Market Growth Factors
Rising prevalence of respiratory diseases
The increasing incidence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, and pneumonia has driven the demand for bronchoscopic procedures for diagnosis and treatment. Lung cancer is one of the leading causes of cancer-related deaths globally. It often requires bronchoscopic procedures for diagnosis, staging, and treatment planning. Early detection and accurate diagnosis through bronchoscopy are critical for improving survival rates. COPD comprises conditions including chronic bronchitis and emphysema. It assess airway inflammation, collect tissue samples for diagnosis, and provide therapeutic interventions to manage symptoms and improve lung function. The rising prevalence of respiratory diseases is a significant driver of growth in the market.
Growing adoption of telemedicine and remote consultations
The growth of telemedicine and remote healthcare services has expanded the reach of bronchoscopic procedures. Video bronchoscopes enable healthcare professionals to conduct remote consultations and collaborate with specialists. Telemedicine authorizes patients in remote or underserved areas to access healthcare services, including bronchoscopic consultations and follow-up care, without traveling long distances to a healthcare facility. Telemedicine enables healthcare providers to conduct remote consultations with patients. Bronchoscopic findings, images, and videos can be shared with specialists for evaluation and recommendations, allowing expert input regardless of geographical location. The growth of telemedicine and remote healthcare services has significantly impacted the market.
Market Restraining Factors
Higher risk of infection transmission
Bronchoscopic procedures carry the risk of infection transmission. Ensuring proper cleaning, disinfection, and sterilization of bronchoscopes is crucial to prevent healthcare-associated infections. Bronchoscopes are intricate medical devices with multiple channels and components, which makes them challenging to clean thoroughly. Contaminants, including microbial biofilms, can hide in crevices and channels, increasing the risk of infection transmission. Human error during the cleaning and reprocessing of bronchoscopes is a significant concern. Manual cleaning, disinfection, or sterilization errors can leave behind contaminants that harbour infectious agents. This can result in delayed recognition of infection clusters or outbreaks. The risk of infection transmission associated with bronchoscopes presents a significant challenge in the healthcare industry and the market.
Type Outlook
Based on type, the market is classified into rigid and flexible. The fiberoptic segment garnered a significant revenue share in the market in 2022. Flexible bronchoscopes have a smaller diameter and are less invasive, which can reduce patient discomfort and anxiety during the procedure. Flexible bronchoscopes are highly versatile and can be used for various diagnostic and therapeutic procedures. They are suitable for visualizing the entire respiratory tract, including the bronchi and peripheral airways. Flexible bronchoscopes are easier to maneuver and navigate through the airways due to their flexibility. The advantages of flexible bronchoscopes include their patient-friendly design, versatility, advanced imaging capabilities, and suitability for various diagnostic and therapeutic applications. They have become a standard tool in respiratory medicine and play a significant role in diagnosing and treating lung and airway disorders.
Flexible Outlook
Under flexible type, the market is divided into video, fiberoptic, and hybrid. The fiberoptic segment garnered a significant revenue share in the market in 2022. Fiberoptic bronchoscopes are commonly used for diagnostic purposes. They allow healthcare providers to examine the bronchial tree and detect abnormalities like tumours, infections, foreign bodies, and inflammation. The optical clarity provided by fiberoptic bundles enables precise visualization. Fiberoptic bronchoscopes are used to inspect the airway, assess airway patency, and identify any obstructions or lesions. They are valuable tools for evaluating patients with respiratory symptoms, including cough, hemoptysis, and wheezing. Fiberoptic bronchoscopes are used to locate and remove foreign objects, such as food particles or inhaled objects, from the airway. Their flexibility and maneuverability aid in precision during these procedures.
Usage Outlook
By usage, the market is categorized into reusable and disposable. The disposable segment covered a considerable revenue share in the market in 2022. Disposable bronchoscopes are manufactured under controlled conditions, ensuring that each scope is optimal. This consistency can be especially important for critical procedures where image quality and functionality are essential. Healthcare providers find disposable bronchoscopes convenient because they can be used immediately without the need for setup, calibration, or sterilization. This can be particularly advantageous in emergencies. Disposable bronchoscopes are well-suited for use in remote or field settings where access to reprocessing facilities is limited or impractical.
End Use Outlook
On the basis of end-use, the market is segmented into hospitals and outpatient facilities. In 2022, the hospitals segment registered the maximum revenue share in the market. Hospitals use bronchoscopes for diagnostic purposes. These procedures involve the insertion of the bronchoscope into the patient's airways to visualize the trachea, bronchi, and bronchioles. This helps identify abnormalities like tumours, infections, inflammation, and bleeding. It enables the collection of tissue samples from the airways, which are then sent to the pathology department for analysis. Hospitals utilize bronchoscopes for therapeutic purposes. They can be used to deliver medications, perform bronchial thermoplasty for asthma management, or treat conditions like hemoptysis (coughing up blood) or strictures (narrowing of airways).
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The region's advanced healthcare infrastructure enables the adoption of the latest medical technologies and devices, including bronchoscopes. High-quality healthcare facilities and a skilled workforce contribute to the market's growth. North America is a hub for medical technology innovation. Manufacturers in the region continually develop and introduce advanced bronchoscope technologies, such as digital video bronchoscopes with high-definition imaging, enhanced manoeuvrability, and integration with digital systems.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Olympus Corporation, Ambu A/S, Karl Storz SE & Co. KG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Cook Medical, Inc. (Cook Group), Medtronic PLC, Johnson & Johnson, Richard Wolf GmbH (The Richard and Annemarie Wolf Foundation)
Recent Strategies Deployed in Bronchoscopes Market
Product Launches and Product Expansions:
Jan-2023: Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope.
Nov-2022: Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter. Additionally, it has a teardrop-shaped dial which facilitates smooth handling during procedures.
Jul-2022: Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.
Apr-2021: Olympus Corporation announced the launch of H-SteriScope Single-Use Bronchoscopes, a series of five single-use endoscopes used for diagnostic and therapeutic procedures. The bronchoscopes feature an outer diameter range of 2.2 to 6.2 mm and working channels that span 1.2 to 3.2 mm. Additionally, the bronchopes have a rotary function for east positioning and Tip Angulation for easy target access.
Mergers & Acquisition:
Sep-2021: Boston Scientific Corporation took over the international surgical business of Lumenis, a medical device manufacturer based in Israel. The acquisition complements Boston Scientific's kidney stone management portfolio and expands its presence in Europe and Asia.
Jun-2021: Boston Scientific Corporation announced the acquisition of Farapulse Inc., a medical device manufacturing company. The acquisition complements and strengthens Boston Scientific's electrophysiology portfolio.
Partnerships, Collaborations & Agreements:
Apr-2023: Fujifilm Holdings Corporation partnered with Tata Memorial Center, an Indian cancer research institute, to establish a training facility in the Tata Memorial Center. The partnership comes in line with Fujifilm's aim to improve healthcare in the Indian market.
Trials and Approvals:
Jul-2022: Ambu A/S received approval from the US FDA for its Ambu aScopeTM 5 Broncho, a series of single-use sterile bronchoscopes.
Aug-2021: Boston Scientific Corporation announced the US FDA approval for its announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT Model B Single-Use Bronchoscope. The EXALT Model B Bronchoscope is used for a variety of bronchoscopy procedures including secretion management, percutaneous tracheostomy, airway intubation, etc.
Market Segments covered in the Report:
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Usage (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Billion/Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research